Just after winning the Gründerprisen 2024, Madsnor received another major boost — confirmation from the Research Council of Norway that we had been awarded NOK 5 million in funding for a Verification Project. This grant enables us to take significant steps forward in the development and commercialization of our technology.
The project includes several work packages aimed at:
· Developing and testing a complete MADS® prototype
· Planning a clinical trial
· Meeting all quality requirements for both the product and the organization
· Developing and launching a comprehensive business and marketing strategy
Out of more than 90 applications, only 20 were approved. We see Madsnor’s selection as a strong vote of confidence from external experts and the Research Council’s review panel — a clear recognition of the potential of the MADS® system and our commercial strategy.
.svg)
.svg)
.svg)
.svg)
.svg)